NEW YORK (GenomeWeb) – Bio-Techne said today that its 2019 fiscal third quarter revenues rose 13 percent year over year, driven by double-digit organic growth in North America, Europe, and China.
For the three months ended March 31, 2019 the Minneapolis, Minnesota-based firm said revenues rose to $184.9 million year over year from $164.0 million, beating analysts' average estimate of $182.9 million.